Health

  • April 13, 2026

    Obesity Drugmaker Leads 2 Biotech Startups Eyeing IPOs

    Two biotechnology startup companies on Monday filed plans for their public debuts, with obesity-focused Kailera Therapeutics planning to raise an estimated $500 million in its initial public offering and protein biomarker detection platform Alamar Biosciences planning to raise around $150 million.

  • April 13, 2026

    Mylan Can't Revive Copaxone Antitrust Claims Against Teva

    A New Jersey federal judge sided Monday with a special master's recommendations to nix some of the parallel claims from Mylan and retailers like Walgreens accusing Teva of using regulatory deception, false advertising, improper rebates and more to delay generic competition to its Copaxone multiple sclerosis treatment.

  • April 13, 2026

    Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case

    Hikma Pharmaceuticals USA Inc. told the U.S. Supreme Court on Monday that the justices' recent decision clearing an internet company in a copyright case bolsters the drugmaker's challenge to a patent suit over its generic version of an Amarin Pharma Inc. heart drug.

  • April 13, 2026

    AI Cardiac Imaging Co. Hits Ex-Consultant With IP Suit

    Artificial intelligence-powered cardiac imaging company Heartflow Inc. filed patent infringement and trade secret misappropriation claims on Monday against a competitor founded by a former consultant who, the company says, lifted technological trade secrets while he was under contract.

  • April 13, 2026

    Texas GLP-1 Compounder Caused Mom's Death, Family Says

    A Houston compounding pharmacy misled consumers by marketing its weight loss and diabetes drugs as safe and pharmaceutical-grade while selling contaminated medicines, a deceased Texas woman's family claims in a wrongful death lawsuit, alleging the drugs led to the woman's death. 

  • April 13, 2026

    11th Circ. Backs FDA's Ban Over Drug Tester's Conviction

    The Eleventh Circuit on Monday backed a U.S. Food and Drug Administration order barring a former pharmaceutical worker from future interaction with the agency after she was convicted of lying during an investigation of her company, rejecting her bid for judicial review of the decision.

  • April 13, 2026

    Chamber, Other Biz Groups Back Insulin Cos. At High Court

    The U.S. Chamber of Commerce and other business groups urged the U.S. Supreme Court to take up an appeal from Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing the Second Circuit's revival of an antitrust suit risks opening up liability just for trade group membership.

  • April 13, 2026

    Ex-Med Spa Workers Settle Conn. Poaching Claims

    A Connecticut medical spa has settled a state court lawsuit accusing two former employees of luring clients and a colleague to a similar facility less than six miles away, court records show.

  • April 13, 2026

    Abbott Urges Toss Of Relator, State Suits In FCA Recall Row

    Abbott Laboratories urged a Michigan federal court to throw out litigation brought by whistleblowers and a group of states over the 2022 infant formula shortage, saying their respective complaints lacked the details necessary to support claims that it defrauded numerous healthcare programs.

  • April 13, 2026

    ITC Will Find Out If Imported Pain Patches Infringe Patent

    Imported over-the-counter lidocaine patches sold by five companies in the U.S. are facing possible exclusion orders after the U.S. International Trade Commission on Monday said it would open an investigation into claims that they infringe a patent on such patches.

  • April 13, 2026

    Retrial Ordered In $18M Heart Surgery Malpractice Case

    A Georgia state court judge has ordered a redo of a medical malpractice trial that landed an $18 million verdict for the family of a man who died weeks after surgery, ruling that her decision to not grant a mistrial over the family's opening statements "was unfair and led to a prejudicial error."

  • April 13, 2026

    Holland & Knight Adds Healthcare Pro In Dallas From Dykema

    Holland & Knight LLP announced Monday that it has deepened its healthcare transactions practice with a Dallas-based partner who came aboard from Dykema Gossett PLLC.

  • April 13, 2026

    Senior Housing, Healthcare REIT Seeks $1.1B Value In IPO

    Real estate investment trust National Healthcare Properties Inc. is seeking to reach a valuation of about $1.1 billion in an upcoming initial public offering advised by Paul Weiss Rifkind Wharton & Garrison LLP, Greenberg Traurig LLP and Sidley Austin LLP.

  • April 13, 2026

    NC High Court Snapshot: State Retirees Fight To Retain Class

    The North Carolina Supreme Court in April will tackle a long-simmering fight over the state's obligations to provide health insurance to retired public employees, who are battling to keep their class status.

  • April 10, 2026

    Chest Binders Become Latest Front In Anti-Trans Litigation

    Chest binders — medical devices that can be used by individuals experiencing gender dysphoria or who want a more gender-neutral alternative to bras — have emerged as the newest target in an unfolding regulatory and legal climate that transgender advocates describe as an overtly partisan political attack against a type of product that the U.S. Food and Drug Administration has deemed the least risky.

  • April 10, 2026

    Allstate Says Texas Family Stole $7.9M In Medical Billing Scam

    A Texas family and their collection of companies carried out a scheme to defraud Allstate out of $7.9 million by submitting false records and bills for unnecessary medical services purportedly provided to motor vehicle crash victims, the insurer alleged in a suit filed in Texas federal court Friday.

  • April 10, 2026

    Wisconsin High Court OKs COVID Immunity For Hospitals

    A Wisconsin state appeals court erred when it held that a statute shielding healthcare providers from civil liability during the early months of the COVID-19 pandemic violated a woman's constitutional right to a jury, the state's highest court ruled unanimously Friday.

  • April 10, 2026

    Colo. Transport Co. Says Termination Lacked Due Process

    A medical transportation company that provided transportation services for Medicaid users in Denver asked a Colorado state judge to reverse a termination of its services from the state, claiming the statute used to issue the termination against the company is unconstitutional.

  • April 10, 2026

    Fla. Panel Tosses Sex Abuse Claims, Finds They're Med Mal

    A Florida appeals panel on Friday freed a supervising physician and a nursing company from a suit alleging a physician sexually abused a patient during a vaginal exam, finding the claims were based in medical malpractice and the plaintiffs hadn't properly given presuit notice.

  • April 10, 2026

    Compass Group Workers Get Cert. For Tobacco Fee Suit

    Former employees for food service company Compass Group USA have secured class certification for their Missouri federal lawsuit claiming the company's $48 bi-weekly health insurance fee for tobacco using-workers violates federal law.

  • April 10, 2026

    Colo. College Drops Suit Against State's Higher Ed Dept.

    A Colorado college that trains students in medical sales has dismissed its February lawsuit in state court against the Colorado Department of Higher Education for shutting down the school's operations.

  • April 10, 2026

    Texas Justices Block New Trial Over Man's Amputated Finger

    The Supreme Court of Texas on Friday reversed an order calling for a new trial for a man suing his plastic surgeon over the loss of his finger, saying none of the trial court's reasoning for granting the new trial holds water.

  • April 10, 2026

    Chinese Scholar Gets Time Served For Smuggling E. Coli DNA

    A Chinese postdoctoral research associate at Indiana University was sentenced to time served on Wednesday by an Indiana federal judge, spending more than four months in custody on smuggling charges for shipping an E. coli sample from China into the U.S. and lying about it when questioned by U.S. Customs and Border Protection agents. 

  • April 10, 2026

    Mich. Care Staff Not Paid For Working Meal Breaks, Suit Says

    A former senior care facility employee has filed a proposed Fair Labor Standards Act collective action in Michigan federal court, claiming the assisted living and memory care center shortchanged hourly workers on overtime in two ways — by automatically deducting meal breaks they spent working and by excluding bonus pay from their regular rate.

  • April 10, 2026

    Philip Morris Urges 11th Circ. To Affirm FDA Rule Toss

    Philip Morris urged the Eleventh Circuit to affirm a decision that struck down a U.S. Food and Drug Administration rule calling for graphic warnings on cigarette packaging, arguing a district court rightly found the FDA had not followed proper procedure when crafting the regulations.

Expert Analysis

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • Health, Legal Employers Face Unique Online Speech Hurdles

    Author Photo

    Employers in the legal and healthcare industries must consider distinctive ethical obligations and professional requirements when disciplining employees for social media posts, while anticipating an area of the law in flux as courts seek to balance speech rights and the workplace function, say attorneys at FordHarrison.

  • Reviewing 2025's Most Pertinent Wiretap Developments

    Author Photo

    2025 was a remarkable year in the world of web tracking wiretapping litigation, not only for the increased caseload but also because of numerous developing theories of liability, with disputes expected to continue unabated in 2026, say attorneys at Squire Patton.

  • 2025 Legal Milestones That Will Shape Psychedelics Sector

    Author Photo

    As 2025 draws to a close, psychedelic drug development stands at an inflection point, experiencing unprecedented momentum through recent sweeping regulatory changes and landmark clinical milestones, amid rapidly evolving regulatory expectations, say Odette Hauke at Odette Alina LLC and Kimberly Chew at Husch Blackwell.

  • Series

    Nature Photography Makes Me A Better Lawyer

    Author Photo

    Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.

  • 2025 State AI Laws Expand Liability, Raise Insurance Risks

    Author Photo

    As 2025 nears its end, claims professionals should be aware of trends in state legislation addressing artificial intelligence use, as insurance claims based on some of these liability-expanding statutes are a certainty, say attorneys at Wiley.

  • Series

    Law School's Missed Lessons: Practical Problem Solving

    Author Photo

    Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.

  • Intellectual Property Challenges In AI-Driven Drug Discovery

    Author Photo

    Given the adoption of artificial intelligence-based drug discovery platforms and the U.S. Patent and Trademark Office's recent guidance on determining inventorship in AI-assisted inventions, practitioners must consider unprecedented questions regarding inventorship, patentability standards and infringement liability, says Paul Calvo at Sterne Kessler.

  • Learning From 2025 FCA Trends Targeting PE In Healthcare

    Author Photo

    False Claims Act enforcement trends and legislative developments from this year signal intensifying state and federal scrutiny of private equity's growing footprint in healthcare, and the urgency of compliance, says Lisa Re at Arnold & Porter.

  • Opinion

    A Uniform Federal Rule Would Curb Gen AI Missteps In Court

    Author Photo

    To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.

  • Riding The Changing Winds For AI Innovations At The USPTO

    Author Photo

    As recent U.S. Patent and Trademark Office moves reshape how artificial intelligence inventions will be examined and put them on firmer eligibility footing, practitioners need to consider how this shift is both an opportunity and a challenge, say Ryan Phelan at Marshall Gerstein and attorney Mark Campagna.

  • Series

    The Law Firm Merger Diaries: Integrating Practice Groups

    Author Photo

    Enacting unified leadership and consistent client service standards ensures law firm practice groups connect and collaborate around shared goals, turning a law firm merger into a platform for growth rather than a period of disruption, says Brian Catlett at Fennemore Craig.

  • Nonprofits Face Uncertainty Over Political Activity Rules

    Author Photo

    Two federal court decisions suggesting that the Internal Revenue Service's rules for 501(c)(4) organizations' political activity may be too vague to survive constitutional scrutiny leave nonprofit organizations caught between constitutional limits on government regulation of speech and tax limits on their exempt status, say attorneys at BakerHostetler.

  • Opinion

    Supreme Court Term Limits Would Carry Hidden Risk

    Author Photo

    While proposals for limiting the terms of U.S. Supreme Court justices are popular, a steady stream of relatively young, highly marketable ex-justices with unique knowledge and influence entering the marketplace of law and politics could create new problems, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.

  • Next Steps For Orgs. Amid Updated OpenAI Usage Policies

    Author Photo

    OpenAI's updates to its usage policies, clarifying that its tools are not substitutes for professional medical, legal or other regulated advice, sends a clear signal that organizations should mirror this clarity in their governance policies to mitigate compliance and liability exposure, say attorneys at Baker Donelson.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.